Lixisenatide belongs to the category of GLP-1 receptor agonists, which effectively controls blood sugar levels by promoting insulin secretion, inhibiting glucagon release, and delaying gastric emptying. For patients who are not effective in diet control and exercise therapy, lixisenatide can be used as a supplement to insulin therapy and has shown good cardiovascular safety.